The most quoted number from Rocket Doctor’s August 18 provider network agreement is that the network it joined serves approximately 60 million consumers across more than 700 health plans and over 100,000 employers. Read quickly, that figure can sound like a patient-acquisition claim. It is not one.

The 60 million figure describes the scale of the national network Rocket Doctor now has contracted access to, not a count of people currently covered as Rocket Doctor patients. Participation, plan eligibility, and individual benefit rules still determine which of those consumers can actually reach a Rocket Doctor physician, and under what terms.

That distinction is central to how investor Yazan Al Homsi has framed the deal. A Rocket Doctor shareholder through Founders Round Capital, he draws no salary from the company and holds no operating role in it — a disclosure he has made directly rather than leaving for readers to assume. His view treats the network size as addressable opportunity rather than guaranteed volume, a caveat he has laid out in more detail on his website.

None of this makes the number meaningless. A network of that size gives Rocket Doctor a considerably larger pool of potential patients to convert than it had before, and it removes some of the one-off negotiation that otherwise slows state-by-state expansion. Whether that translates into revenue is a separate question from network scale, and it is the one that will ultimately validate or undercut the reading Al Homsi has laid out on his LinkedIn profile.